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Abstract
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Objective—To use the minimal important difference (MID) versus standardized mean difference
(SMD) approach to provide more robust and clinically relevant information regarding the
association between land-based aerobic exercise and changes in self-reported fatigue among adults
with rheumatoid arthritis (RA).
Methods—Data from a previous meta-analysis of five randomized controlled trials representing
up to 298 participants per study were used to calculate nine effect sizes (ES) using the MID
approach. Minimal important difference data were derived from previously reported anchor-based
values specific to each fatigue instrument in adults with RA. Results were pooled using a randomeffects model.
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Results—Aerobic exercise resulted in statistically significant reductions in self-reported fatigue
(MID ES, −0.34, 95% CI, −0.58 to −0.10, p = 0.006). Findings were similar when ESs were
collapsed so that only one ES represented each study (MID ES, −0.39, 95% CI, −0.76 to −0.03, p
= 0.04). However, using previous cut points, it may be unlikely that a large number of participants
with RA could derive clinically relevant reductions in fatigue.
Conclusions—Land-based aerobic exercise is associated with statistically significant reductions
in fatigue. However, it may be unlikely that a substantial number of participants with RA could
obtain clinically-relevant reductions in fatigue. A need exists for additional studies, especially in
RA participants with elevated levels of fatigue.
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INTRODUCTION
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Rheumatoid arthritis (RA) is a common autoimmune disease that affects approximately 1%
of the population worldwide (1). More common in women than men (2), the total annual
costs attributed to RA in the United States in 2005 were estimated at $19.2 billion (3). One
of the most common patient-reported outcomes reported by participants with RA is fatigue,
a condition which may be described as a “sensation of exhaustion during or after usual
activities, or a feeling of inadequate energy to begin these activities” (4). However, this
definition does not capture the sensation that RA participants report in feeling that fatigue is
unrelated to energy expenditure and unpredictable. The prevalence of fatigue in RA
participants has been reported to be between 41% and 80% (5–9), with differing findings
most likely the result of variations in the definitions and instruments used to assess fatigue as
well as the lack of a gold standard instrument for assessing such. One potential nonpharmacological therapy for the treatment of fatigue in adults with RA is exercise. A recent
meta-analysis by Rongen-van Dartel, et al., limited to randomized controlled trials of
supervised land-based aerobic exercise in adults with RA found a statistically significant,
standardized mean difference (SMD) effect size (ES) improvement of −0.31 (p = 0.02) in
fatigue after ≤ 12 weeks of exercise but a non-statistically significant decrease after ≥ 24
weeks (ES, −0.15, p = 0.9) (10). While these results are informative, the use of the SMD
approach for calculating ESs is influenced by factors such as the heterogeneity of the
population and is not easily interpreted by clinicians and other healthcare providers (11).
Alternatively, reporting ES results in minimal important difference (MID) units has been
suggested as a potential solution to address problems associated with existing methods such
as the SMD approach (11). Given the potential benefits of exercise on fatigue in adults with
RA as well as the need for potentially more valid and easily interpretable information for
decision-makers, the purpose of this paper was to apply the MID approach for the
calculation of ESs to the recent meta-analysis of Rongen-van Dartel, et al., in order to
determine the practically-relevant effects of exercise on fatigue in adults with RA (10).
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MATERIALS AND METHODS
Data source
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Data for this brief report were derived from a recently published systematic review with
meta-analysis on the association between exercise and fatigue in adults with RA (10) as well
as examining the original five studies that were included in the meta-analysis (12–16).
Briefly, studies were limited to randomized controlled trials of supervised, land-based
aerobic exercise lasting at least four weeks in adults with RA and in which fatigue was
assessed as an outcome (10). The five studies (12–16) included in the meta-analysis (10)
yielded 9 ESs representing 29 to 281 participants per study (17 to 136 exercise and 12 to 145
control). Ages of the eligible participants within each study ranged from 20 to 80 years
while the percentage of females ranged from 59% to 82.7% (12–16). Training modalities
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included cycling, running, and circuit training 2 to 3 times per week for ≥ 15 minutes per
session (10). Length of training ranged from 4 to 104 weeks (10). This included 104 weeks
of exercise in one study (12), 12 and 24 weeks in two studies (13, 14), 8 and 24 weeks in
one study (15), and 4 and 24 weeks in another (16). Assessment was conducted using the
Multidimensional Assessment of Fatigue (MAF) Instrument in 3 studies (13–15), and either
the Vitality subscale of the SF-36 (SF-36-V) (12) or Visual Analog Scale for Fatigue (VASF) (16) in one study each (10). Effect sizes in the original meta-analysis (10) were calculated
using the SMD and pooled using the original random-effects, method-of-moments approach
of Dersimonian and Laird (17). The overall findings were reported according to short-term
(≤ 12 weeks) and long-term (≥ 24 weeks) land-based aerobic exercise (10). However, no
rationale was provided to support this dichotomization (10).
Data synthesis
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Given that fatigue is measured using different instruments with different scales, results need
to be standardized so they can be pooled in a meta-analysis. For the current meta-analysis,
the SMD ES was calculated using the same procedure as the original meta-analysis (10).
Briefly, and as described in more detail elsewhere (11), this consisted of taking the mean
difference in fatigue for each study, dividing by the standard deviation in each study, and
then pooling across studies. The MID ES was calculated by replacing the denominator of the
SMD, i.e., the standard deviation, with the MID. Thus, the MID ES was calculated by
dividing the mean difference by the MID established for that instrument. The MID was
defined as “the smallest difference in the outcome of interest that informed patients or
informed proxies perceive as important, either beneficial or harmful, and which would lead
the patient or clinician to consider a change in management” (18). Instrument-specific MIDs
were obtained from a previous systematic review (19). Finally, when results are standardized
by dividing the mean difference by the MID, the scale in which the meta-analysis is
conducted is changed. To account for this change, previously recommended formulas were
used (11).
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The a priori plan was to pool ESs similar to the approach used in the meta-analysis of
Rongen-van Dartel, et al.(10), in which results were pooled using a random-effects model
and partitioned according to short term (≤ 12 weeks) and long term (≥ 24 weeks) changes in
fatigue. However, a post hoc decision was made to not analyze the data according to short
and long-term exercise given the lack of research to support such cut points. In addition, a
two-tailed, z-distribution, random-effects, method-of-moments meta-regression was
conducted in which no statistically significant association was found between length of
training, in weeks, and SMD ES changes in fatigue (β1 = 0.0027, 95%, −0.0006, 0.0060, z =
1.62, p = 0.11). Consequently, data were initially analyzed by treating all 9 results from the 5
studies (12–16) as separate ESs. However, because multiple ES results for fatigue from the
same RA participants were nested in four studies (13–16), resulting in a lack of
independence, analyses were also conducted by pooling multiple results from the same study
into one ES so that only one ES represented each study. Non-overlapping 95% confidence
intervals and alpha values ≤0.05 were considered statistically significant. Based on prior
suggestions, ESs >1 based on the MID were indicative of numerous participants deriving
important benefits from the effects of land-based aerobic exercise on fatigue, an ES between
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0.5 and 1.0 indicative of a considerable number of participants benefitting, while an ES <0.5
suggested that it was progressively less likely that a substantial number of participants would
benefit (11). Heterogeneity was examined using the Q statistic, with alpha values ≤ 0.10
considered statistically significant. Inconsistency was examined using the I2 statistic and the
same cut points used in the original meta-analysis: <25% (low), 25% to 75% (moderate),
≥75% (large) (10). Absolute between-study variance was calculated using tau-squared (τ2).
Because the number of ESs was low (n = 9), results were also calculated with each ES
deleted from the model once given the possibility that one ES could have a significant
impact on the overall pooled results. Based on current guidelines, small-study effects
(publication bias, etc.) were not examined because the number of ESs in each subgroup was
less than 10 (20). Effect sizes were calculated using Microsoft Excel 2013 while data were
analyzed using MetaXL, version 5.3 as well as Comprehensive Meta-Analysis, version 3.3.
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RESULTS

Author Manuscript

Individual ES results (n = 9) from each study, partitioned according to the SMD and MID
ES approaches, are shown in Figure 1. As can be seen, statistically significant and nonoverlapping 95% CI’s were observed for both the SMD (p = 0.004) and MID (p = 0.006).
No statistically significant heterogeneity was observed and inconsistency was considered
low. Tau-squared (τ2 ) was 0 for the SMD approach and 0.01 for the MID approach. The
overall MID ES of −0.34 suggests that it is unlikely that a large number of participants with
RA would derive clinically important reductions in fatigue by participating in land-based
aerobic exercise (11). When ES results were collapsed so that only one ES represented each
study (n = 5), similar results were observed (Figure 2). Statistically significant and nonoverlapping 95% CI’s were again observed for both the SMD (p = 0.02) and MID (p = 0.04).
No statistically significant heterogeneity was observed for SMD results and inconsistency
was considered moderate. For the MID approach, statistically significant heterogeneity and
moderate inconsistency were observed. Tau-squared (τ2 ) was 0.02 for SMD ESs and 0.08
for MID ESs. The overall MID ES of −0.39 again suggests that it is unlikely that a large
number of participants with RA would derive clinically-relevant reductions in fatigue from
land-based aerobic exercise (11).
With each result deleted from the model once, ES changes in fatigue based on the SMD
ranged from −0.29 to −0.17 when treating each ES separately as well as when results were
collapsed so that only one ES represented each study. For MID ESs, changes ranged from
−0.54 to −0.26 when treating each ES separately to −0.55 to −0.25 when results were
collapsed so that only one ES represented each study.
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DISCUSSION
This study provides clinically relevant information regarding the effects of supervised landbased aerobic exercise on self-reported fatigue in adults with RA. Specifically, based on both
the SMD and MID ES approaches, the overall findings suggest that land-based aerobic
exercise can yield statistically significant reductions in self-reported fatigue in those with
RA. However, based on the MID ES and recommended cut points (11), it may be unlikely
that a large number of participants with RA would derive clinically-relevant benefits.
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Importantly however, land-based aerobic exercise did not appear to increase fatigue. This is
noteworthy given the numerous other benefits that can be derived from exercise in those
with chronic conditions (21, 22). Specific to RA participants, these include, but are not
necessarily limited to, improvements in physical function (23–26), disease activity (23),
quality-of-life (24), and pain (24). In addition, previous research has reported no serious
adverse events (26) or increases in disease activity as a result of exercise (23, 24).
The direction of findings are in general agreement with the overall results reported in the
original meta-analysis of Rongen-van Dartel et al.(10), and in which ESs were based on
using the pooled standard deviation versus MID in the denominator (10).
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From the authors’ perspective, there are several strengths to the current study. First, the
current study included the calculation of ESs using the MID approach (11). Such an
approach helps to circumvent the problems associated with between-study variances based
on the pooled standard deviation, i.e., the SMD approach (11). Specifically, these include the
influence of heterogeneity in the population as well as the lack of intuitiveness for clinicians
and other healthcare providers (11). A second and related strength was the generation of
findings that provide more robust and clinically relevant information for decision-makers
(11). The rationale for the MID ES being more clinically relevant is grounded in the fact that
it is based on scores that clinicians, patients or their proxies perceive as important and which
could result in a decision to make a change in the management of the participant’s condition
(11, 18). A third strength was the availability of anchor-based MID data specific to each
instrument in RA participants. As a result, the use of alternative approaches such as relying
on MID data from other populations (cancer patients, etc.) or the use of distribution-based
methods was avoided (11).
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While the current study has several strengths, there are also potential limitations. First, and
as pointed out in the original meta-analysis, none of the original studies included in the
meta-analysis limited participants to those with elevated levels of fatigue (10). As a result,
the value of exercise may not have been realized in those who may have the most to gain
from such. Second, some may consider the MID ES cut points used for determining clinical
relevance as somewhat arbitrary (11). However, the same can be true for the suggested cut
points used for the SMD ES (27–29). Therefore, given the greater clinical relevance, it is
suggested that the MID ES be the metric of choice when instruments using two or more
different scales are used to assess the same outcome. This is of course assuming that MID
data are available for each instrument and in the participant population of interest. For
example, in the current study, MID values were available for each instrument that assessed
fatigue in participants with RA (19). In contrast, unpublished results from the authors have
shown that no MID data exist for instruments that assess anxiety in participants with RA.
In conclusion, the results of the current study suggest that land-based aerobic exercise is
associated with statistically significant reductions in fatigue. While it may be unlikely that a
large number of participants with RA could obtain clinically-relevant reductions in fatigue as
a result of land-based exercise, they are likely to have meaningful improvements in other
symptoms with some improvement in fatigue. A need exists for additional studies on this
topic, especially in RA participants with elevated levels of fatigue.
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SIGNIFICANCE AND INNOVATIONS
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•

This is the first meta-analysis to use the more robust and clinically relevant
minimal important difference (MID) approach to examine the effects of
supervised, land-based aerobic exercise on self-reported fatigue in adults with
rheumatoid arthritis.

•

The findings suggest that participation in land-based aerobic exercise results
in statistically significant reductions in fatigue but it may be unlikely that a
large number of participants with rheumatoid arthritis could derive clinically
important reductions in fatigue.

•

Supervised, land-based aerobic exercise did not increase self-reported fatigue
in adults with rheumatoid arthritis.

•

Because they may have the most to gain, future exercise research should focus
on rheumatoid arthritis participants with elevated levels of self-reported
fatigue.
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Figure 1.

Forest plot representing individual effect sizes (ES) for fatigue, grouped according to the
standardized mean difference (SMD) and minimal important difference (MID) approaches.
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Figure 2.

Forest plot representing study-level effect sizes (ES) for fatigue, grouped according to the
standardized mean difference (SMD) and minimal important difference (MID) approaches.
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